Key Highlights
- RSV vaccines shown to dramatically reduce hospitalizations.
- U. S. officials recommend RSV shots only for high-risk babies.
- New restrictions announced affect one-third of routine childhood vaccines.
Evidence shows benefit of RSV vaccines as Trump officials push restrictions
New evidence highlights the effectiveness of RSV vaccines in significantly reducing hospitalizations, despite U. S. officials moving to restrict their use primarily to high-risk infants. This decision comes amidst ongoing discussions about the broader implications of vaccine availability for children.
Credit: Theguardian
Loading ad...
Loading ad...
Sources
This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.
Related Stories
Dark, Velvety Patches on Skin May Signal Insulin Resistance, Early Diabetes Risk
Health
January 14, 2026
First leukaemia patient to receive pioneering treatment on NHS says it is 'very sci-fi'
Health
January 14, 2026
One in four UK teenagers in care have attempted to end their lives, study says
Health
January 14, 2026